A Phase II Trial of Ifosfamide, Etoposide, Cytarabine, and Methotrexate (IVAM) Chemotherapy for Refractory or Relapsed Diffuse Large B Cell Lymphoma

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2016
A phase II trial of ifosfamide, etoposide, cytarabine, and methotrexate (IVAM) chemotherapy for refractory or relapsed diffuse large B cell lymphoma
Epistemonikos ID: a583e6a6deb2057c38b9201b30fc6b509decbc88
First added on: May 21, 2024